Page 66 - ஆரோக்கியம் ப்ராடக்ட்ஸ் ஒழுங்குமுறை அதிகாரம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Irish authority to monitor AstraZeneca vaccine inquiry
rte.ie - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from rte.ie Daily Mail and Mail on Sunday newspapers.
Ireland may ask EU countries to share their Covid-19 vaccines
irishtimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from irishtimes.com Daily Mail and Mail on Sunday newspapers.
MarkIt to Market® - February 2021: Watching the Pot™ | Sterne, Kessler, Goldstein & Fox P L L C
jdsupra.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jdsupra.com Daily Mail and Mail on Sunday newspapers.
A hair restoration doctor cleared by a court of illegally importing medicines has taken proceedings to stop a Medical Council hearing over the same matter.
In a case which may have ramifications for investigations by a range of professional bodies, Dr Samuel Van Eeden claims the inquiry breaches his constitutional rights as he has already been cleared of criminal charges.
The South African-born surgeon and his wife Zelda were both charged in connection with the alleged unauthorised importation of the medicines from Bangladesh in 2012.
The medicines included an injected antibiotic for hair restoration treatment, sedatives, drugs for indigestion and cholesterol problems, and a local anaesthetic.
A variant-proof vaccine? Two California firms launch trials of COVID shot they hope will protect against the South African form - and future mutants - by targeting a more stable part of the infectious spike protein
Two biotechnology companies based in California, ImmunityBio and NantKwest, are beginning Phase I clinical trials of their vaccine in South Africa
Their candidate, hAd5 T-cell, targets two parts of the virus: the spike protein, more prone to mutations and the nucleocapsid protein, which is less prone
Researchers hope this will help protect against variants of the coronavirus like those that arose in the UK, South Africa and Brazil